Treatment-resistant depression: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Treatment-resistant depression | |||
| synonyms = TRD | |||
| field = [[Psychiatry]] | |||
| symptoms = [[Depression (mood)|Depressive symptoms]] that do not respond to treatment | |||
| complications = [[Suicide]], [[Substance use disorder]], [[Anxiety disorders]] | |||
| onset = Varies | |||
| duration = Chronic | |||
| causes = Multifactorial, including [[genetic]], [[biological]], and [[environmental factors]] | |||
| risks = [[Family history]] of depression, [[Chronic illness]], [[Stressful life events]] | |||
| diagnosis = Clinical assessment, lack of response to at least two [[antidepressant]] treatments | |||
| differential = [[Bipolar disorder]], [[Personality disorders]], [[Dysthymia]] | |||
| treatment = [[Psychotherapy]], [[Electroconvulsive therapy]], [[Transcranial magnetic stimulation]], [[Ketamine]] | |||
| medication = [[Antidepressants]], [[Atypical antipsychotics]], [[Mood stabilizers]] | |||
| frequency = Affects approximately 10-30% of individuals with [[major depressive disorder]] | |||
}} | |||
'''Treatment-resistant depression''' (TRD) is a term used in clinical psychiatry to describe cases of [[major depressive disorder]] (MDD) that do not respond adequately to appropriate courses of at least two [[antidepressants]]. | '''Treatment-resistant depression''' (TRD) is a term used in clinical psychiatry to describe cases of [[major depressive disorder]] (MDD) that do not respond adequately to appropriate courses of at least two [[antidepressants]]. | ||
==Definition== | ==Definition== | ||
The term "treatment-resistant depression" is generally applied to patients who fail to respond to at least two different trials of antidepressants from different pharmacologic classes, each used for a sufficient duration and at a therapeutic dose. It is important to rule out pseudo-resistance, which can be caused by factors such as noncompliance, inadequate dosing, and substance abuse. | The term "treatment-resistant depression" is generally applied to patients who fail to respond to at least two different trials of antidepressants from different pharmacologic classes, each used for a sufficient duration and at a therapeutic dose. It is important to rule out pseudo-resistance, which can be caused by factors such as noncompliance, inadequate dosing, and substance abuse. | ||
==Epidemiology== | ==Epidemiology== | ||
Treatment-resistant depression is relatively common; estimates suggest that around 30% of patients with MDD could be classified as treatment-resistant. The likelihood of treatment resistance increases with the number of previous depressive episodes. | Treatment-resistant depression is relatively common; estimates suggest that around 30% of patients with MDD could be classified as treatment-resistant. The likelihood of treatment resistance increases with the number of previous depressive episodes. | ||
==Treatment== | ==Treatment== | ||
Treatment options for TRD include switching to a different antidepressant, augmentation with a second medication, and [[psychotherapy]]. More invasive treatments such as [[electroconvulsive therapy]] (ECT) and [[deep brain stimulation]] (DBS) may be considered in severe cases. | Treatment options for TRD include switching to a different antidepressant, augmentation with a second medication, and [[psychotherapy]]. More invasive treatments such as [[electroconvulsive therapy]] (ECT) and [[deep brain stimulation]] (DBS) may be considered in severe cases. | ||
==Switching Antidepressants== | ==Switching Antidepressants== | ||
If a patient does not respond to an antidepressant, a different antidepressant can be tried. This can involve switching within the same class of drugs or to a different class. | If a patient does not respond to an antidepressant, a different antidepressant can be tried. This can involve switching within the same class of drugs or to a different class. | ||
==Augmentation== | ==Augmentation== | ||
Augmentation strategies involve the addition of a second drug to an existing antidepressant. The second drug is often from a different pharmacologic class. Commonly used augmenting agents include lithium and atypical antipsychotics. | Augmentation strategies involve the addition of a second drug to an existing antidepressant. The second drug is often from a different pharmacologic class. Commonly used augmenting agents include lithium and atypical antipsychotics. | ||
==Psychotherapy== | ==Psychotherapy== | ||
Psychotherapy, including cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), can be effective in treating TRD, particularly in patients with psychosocial stressors or interpersonal difficulties. | Psychotherapy, including cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), can be effective in treating TRD, particularly in patients with psychosocial stressors or interpersonal difficulties. | ||
==Invasive Treatments== | ==Invasive Treatments== | ||
In severe cases of TRD where other treatments have failed, more invasive procedures such as ECT or DBS may be considered. These treatments can be effective but also carry risks and are generally reserved for the most severe cases. | In severe cases of TRD where other treatments have failed, more invasive procedures such as ECT or DBS may be considered. These treatments can be effective but also carry risks and are generally reserved for the most severe cases. | ||
==See Also== | ==See Also== | ||
* [[Major depressive disorder]] | * [[Major depressive disorder]] | ||
| Line 28: | Line 37: | ||
* [[Electroconvulsive therapy]] | * [[Electroconvulsive therapy]] | ||
* [[Deep brain stimulation]] | * [[Deep brain stimulation]] | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
[[Category:Depression]] | [[Category:Depression]] | ||
[[Category:Mental health]] | [[Category:Mental health]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 01:54, 4 April 2025
| Treatment-resistant depression | |
|---|---|
| Synonyms | TRD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Depressive symptoms that do not respond to treatment |
| Complications | Suicide, Substance use disorder, Anxiety disorders |
| Onset | Varies |
| Duration | Chronic |
| Types | N/A |
| Causes | Multifactorial, including genetic, biological, and environmental factors |
| Risks | Family history of depression, Chronic illness, Stressful life events |
| Diagnosis | Clinical assessment, lack of response to at least two antidepressant treatments |
| Differential diagnosis | Bipolar disorder, Personality disorders, Dysthymia |
| Prevention | N/A |
| Treatment | Psychotherapy, Electroconvulsive therapy, Transcranial magnetic stimulation, Ketamine |
| Medication | Antidepressants, Atypical antipsychotics, Mood stabilizers |
| Prognosis | N/A |
| Frequency | Affects approximately 10-30% of individuals with major depressive disorder |
| Deaths | N/A |
Treatment-resistant depression (TRD) is a term used in clinical psychiatry to describe cases of major depressive disorder (MDD) that do not respond adequately to appropriate courses of at least two antidepressants.
Definition[edit]
The term "treatment-resistant depression" is generally applied to patients who fail to respond to at least two different trials of antidepressants from different pharmacologic classes, each used for a sufficient duration and at a therapeutic dose. It is important to rule out pseudo-resistance, which can be caused by factors such as noncompliance, inadequate dosing, and substance abuse.
Epidemiology[edit]
Treatment-resistant depression is relatively common; estimates suggest that around 30% of patients with MDD could be classified as treatment-resistant. The likelihood of treatment resistance increases with the number of previous depressive episodes.
Treatment[edit]
Treatment options for TRD include switching to a different antidepressant, augmentation with a second medication, and psychotherapy. More invasive treatments such as electroconvulsive therapy (ECT) and deep brain stimulation (DBS) may be considered in severe cases.
Switching Antidepressants[edit]
If a patient does not respond to an antidepressant, a different antidepressant can be tried. This can involve switching within the same class of drugs or to a different class.
Augmentation[edit]
Augmentation strategies involve the addition of a second drug to an existing antidepressant. The second drug is often from a different pharmacologic class. Commonly used augmenting agents include lithium and atypical antipsychotics.
Psychotherapy[edit]
Psychotherapy, including cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), can be effective in treating TRD, particularly in patients with psychosocial stressors or interpersonal difficulties.
Invasive Treatments[edit]
In severe cases of TRD where other treatments have failed, more invasive procedures such as ECT or DBS may be considered. These treatments can be effective but also carry risks and are generally reserved for the most severe cases.
